secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2025-05-02T23:59:59+00:00
Accession:  0001213900-25-039261
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Estrella Immunopharma receives Nasdaq bid price deficiency notice; faces potential delisting
--------------------------------------------------------------------------------

- Nasdaq notified Estrella that common stock failed to maintain $1.00 minimum bid for 30 consecutive days through April 28, 2025.
- Company has 180-day compliance period (until October 27, 2025) to regain compliance with Bid Price Rule.
- If not compliant by October 27, may seek additional 180-day period if it meets other listing standards.
- No immediate effect on listing; common stock and warrants continue trading on Nasdaq under ESLA and ESLAW.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390025039261/0001213900-25-039261-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390025039261/ea0240454-8k_estrella.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-039261

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer